Tag: Cancer: Breast
New Lesions ID’d on Breast MRI During Treatment Likely Benign
New suspicious lesions detected on breast MRI during neoadjuvant therapy are more likely benign
Clinicians Believe Link Between Breast Pain, Cancer Is Weak
But many order imaging to exclude malignancy or for reassurance only
Lifetime Risk for Brain Mets Up in Elderly With Three Common Cancers
Highest incidence seen for patients with non-small cell lung cancer and triple-negative breast cancer
Medicaid Reimbursement for Breast Radiation Varies by State
Across 48 states and D.C., total episode reimbursement varied from $2,945 to $15,218
Radiotherapy Tied to Lower Recurrence of Early, Hormone-Driven Breast Cancer
Antihormone treatment also recommended in conjunction with radiotherapy
Six Prognostic Factors ID’d for Invasive Disease After DCIS
Six significant factors include African-American race, premenopausal status, detection by palpation
Personalizing Breast Cancer Tx Could Cut Initial Costs of Care
Small decline seen in costs in first 12 months of care with personalized treatment based on recurrence scores
Recurrence Score May Cut Costs for High-Risk Breast Cancer Care
Testing with 21-gene assay linked to lower relative, absolute costs among high-risk patients
Genetic Testing Underused in Breast, Ovarian Cancer
Pathogenic variants ID'd in 7.8 percent of patients with breast cancer, 14.5 percent with ovarian cancer
Guidance Statements Issued for Breast Cancer Screening
Clinicians should discuss mammography with patients aged 40 to 49, discontinue screening for those ≥75
